Tokenized data: the power to deliver robust patient insights in a complex real world

HTA bodies routinely demand real-world evidence (RWE) to support reimbursement decisions for new therapies under consideration. Yet as patient treatment journeys become more complex, encompassing primary, secondary, and multidisciplinary care delivered by different providers with different systems, it becomes more challenging to model those patient treatment journeys for evidence generation.

Capturing the rich evidence in complex patient journeys is possible, however, with tokenized real-world data (RWD). In this whitepaper, OPEN Health’s RWE experts explain what tokenized real-world data (RWD) is and show via two case studies (one US, one UK) how it can be the key to a robust integrated evidence generation plan that satisfies HTA requirements.

We have reserved a copy of this whitepaper for you.

OPEN Health authors – RWE and Market Access Experts:

We are excited to share our latest thinking with you.

Please fill out the form to download the whitepaper.

"*" indicates required fields

Company

This field is for validation purposes and should be left unchanged.

First Name*

Last Name*

Company Name*

Job Title*

Work Email*

Select the solutions you’re interested in (if any)

By submitting your information, you agree to receive communications from OPEN Health. We will use your information in accordance with our Privacy Notice.

At OPEN Health, we connect visionary minds, pioneering science, and advanced technology to drive real impact.

By uniting people, science, and technology, we activate new opportunities for biopharma innovation. Our expertise across medical affairs and market access unlocks faster, smarter routes to market. We are committed to improving patient outcomes worldwide.

Talk to us